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Abstract 
Recent developments in genetics and molecular biology have classified breast cancer into subtypes based on 
tumor markers of estrogen (ER), progesterone (PR) and human epidermal growth Factor-2 receptors (Her-2), with the 
basal-like (ER−, PR−, Her2−) subtype commonly referred to as “triple negative” breast cancer (TNBC) being the most 
aggressive. Prior studies have provided evidence that higher socio-economic status (SES) is associated with increased 
breast cancer risk, likely due to hormone related risk factors such as parity and hormonal contraceptive use. However, 
it is unclear if the relationship between SES and overall breast cancer incidence exists within each subtype, and if this 
association varies by race/ethnicity. Analysis was based on data obtained from the SEER database linked to 2008–2012 
American Community Survey data, and restricted to women diagnosed with breast cancer in 2010. The NCI SES cen-
sus tract SES index based on measures of income, poverty, unemployment, occupational class, education and house 
value, was examined and categorized into quintiles. Age-adjusted incidence rate ratios were calculated comparing 
the lowest to the highest SES groups by subtype, separately for each race/ethnic group. We identified 47,586 women 
with breast cancer diagnosed in 2010. The majority was diagnosed with Her2−/HR+ tumors (73 %), while 12 % had 
triple negative tumors (TNBC). There was a significant trend of higher incidence with increasing SES for Her2−/HR+ 
(IRR Highest vs. Lowest SES: 1.32, 95 % CI 1.27–1.39; p value trend: 0.01) and Her2+/HR+ tumors (IRR Highest vs. Low-
est SES: 1.46, 95 % CI 1.27–1.68; p value trend: 0.01) among White cases. There was no association between SES and 
incidence of HR− subtypes (Her2+/HR− or TNBC). Similar associations were observed among Black, Hispanic and 
Asian or Pacific Islander cases. The positive association between SES and breast cancer incidence is primarily driven by 
hormone receptor positive tumors. To the extent that neighborhood SES is a proxy for individual SES, future studies 
are still needed to identify etiologic risk factors for other breast cancer subtypes.
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Background
Whether measured at the individual or residential area 
level, higher socioeconomic status (SES) has been asso-
ciated with higher breast cancer incidence (Pudrovska 
and Anikputa 2012; Krieger et al. 2010; Vainshtein 2008; 
Yost et al. 2001), with the most consistent results found 
among White women in the U.S. (Yu et al. 2014; Palmer 
et al. 2012; Borugian et al. 2011; Clegg et al. 2009; Reyn-
olds et al. 2005). This association may reflect differences 
in exposure to breast cancer risk factors. For instance, 
women of higher SES in general have lower parity, greater 
use of exogenous hormones, and greater alcohol con-
sumption, all established risk factors for breast cancer 
(Palmer et al. 2012; Suzuki et al. 2005; Heck and Pamuk 
1997). Most of these studies have classified breast cancer 
as a single disease, although recent genetic and molecu-
lar analyses have established the existence of several sub-
types of breast cancer, based on ER, PR, and Her status. 
In order of increasingly aggressive behavior and worse 
prognosis, the subtypes are: Luminal A (ER+ and/or 
PR+, Her2−), Luminal B (ER+ and/or PR+, Her2+), 
and basal-like (ER−, PR−, Her2−), this last subtype also 
commonly referred to as “triple negative” breast cancer 
or TNBC (Morris and Mitchell 2008; Amend et al. 2006).
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The prevalence of TNBC and HR− tumors has been 
shown to be higher among pre-menopausal African-
American women, and it is associated with more aggres-
sive disease and shorter survival (Stark et  al. 2010; 
Fregene and Newman 2005; Agboola et  al. 2013; Gukas 
et  al. 2008; Carey et  al. 2006). Since African-American 
women are more likely to belong to low SES groups, it 
is important to determine if SES differences explain the 
higher prevalence of HR− tumor subtypes in this racial 
group. Such studies could inform etiologic studies that 
consider each subtype separately to identify risk factors 
or biological mechanisms that can be addressed as part of 
intervention studies to reduce the prevalence of aggres-
sive subtypes, and thus reduce racial disparities in breast 
cancer outcomes. However, only a few studies have 
examined the association between SES and breast cancer 
subtypes (Parise et al. 2009; Banegas et al. 2014; Sineshaw 
et al. 2014), and most of those studies utilized data from 
a single US state (Parise et al. 2009; Banegas et al. 2014). 
Furthermore, characterization of SES has been inconsist-
ent, with SES measured at different geographic levels and 
different definitions of SES used.
The current study examines the association between 
SES and breast cancer subtypes among the major US 
racial groups, using an expanded population-based data-
set with a validated composite census tract-level SES 
index. Our research evaluates whether the positive asso-
ciation between SES and breast cancer incidence exists in 
all breast cancer subtypes, and within each racial group, 
utilizing a valid measure of SES and the Surveillance, Epi-
demiology and End Results (SEER) database.
Methods
Data source
The data for this analysis was obtained from the National 
Cancer Institute SEER database linked to the 2008–2012 
American Community Survey data. The SEER 18 popula-
tion-based dataset includes all breast cancer cases diag-
nosed in 2010 in the following SEER cancer registries: 
Atlanta, Connecticut, Detroit, Hawaii, Iowa, New Mex-
ico, San-Francisco-Oakland, Seattle-Puget Sound, Utah, 
Los Angeles, San Jose-Monterey, rural Georgia, Greater 
California, Kentucky and New Jersey. About 28 % of the 
U.S. population is covered by SEER, although the regions 
included tend to be more urban and suburban compared 
with the general U.S. population.
Individual level data
The main outcome variable for this analysis is incidence 
of first primary breast cancer among women ages 20 years 
and older. The subtype classification of breast cancer is 
based on SEER variables relating to the hormone receptor 
status of tumors recorded by the SEER program. TNBC 
is defined as ER−/PR−/Her2−; Luminal A is defined as 
ER+ and/or PR+ HER2−; and Luminal B is defined as 
ER+ and/or PR+, Her2+. Details of the variable coding 
for ER, PR and Her2 have been published elsewhere (How-
lader et al. 2014), and are available through the SEER web-
site (http://seer.cancer.gov/seerstat/databases/ssf/). The 
Her2 recode variable was available only as of 2010; and our 
analysis was based on data from that year. Other individual 
level variables assessed include age at diagnosis, and race/
ethnicity (NH-White:  non-Hispanic White, NH-Black: 
non-Hispanic Black, NH-API: non-Hispanic Asian or 
Pacific Islander, and Hispanic). This study was considered 
exempt by the Institutional Review Board of the University 
of Alabama at Birmingham, since analysis was based on 
publicly available, non-identifiable SEER data.
Census tract SES
The NCI registry-based census tract SES (NCI-SES) 
index was used in this analysis as our SES measure. 
Detailed methodology regarding this index has been pub-
lished previously. Factor analyses was performed on SES- 
related measures identified by Yost et  al. (2001), with 
higher scores corresponding to higher SES. The index is 
based on measures of income, poverty, unemployment, 
occupational class, education and house value. The SES 
scores obtained from factor analysis were divided into 
quintiles with roughly equal proportions of the popula-
tion in each category, ranging from lowest SES to high-
est SES. The SES classification of each census tract was 
assigned to all cancer cases residing in that census tract 
at the time of diagnosis.
Statistical analysis
Age-adjusted incidence rates (and their standard errors) 
per 100,000 women were calculated for breast cancer 
cases using SEER*Stat (Version 8.1.5). Incidence rate 
ratios and 95  % confidence intervals were calculated 
using the Tiwari method (Tiwari et  al. 2006) and age-
adjusted to the U.S. standard population stratified by 
race/ethnicity (Tiwari et  al. 2006). Frequencies and per-
centages were calculated for each age group, race/ethnic-
ity, SES, disease stage and grade overall and by subtype.
Results
In 2010, 47,586 women were diagnosed with breast can-
cer and met our eligibility criteria; the majority of cases 
(n  =  34,753, 73  %) were diagnosed with Her2−/HR+ 
tumors, and 5764 (12  %) had triple negative tumors 
(TNBC). Table  1 provides descriptive statistics for the 
breast cancer subtypes. NH-Blacks comprised about 9 % 
of all breast cancer cases, and of those, 22 % were diag-
nosed with the TNBC subtype and 61  % with Her2+/
HR− subtype. In contrast, NH-Whites comprised 72 % of 
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all breast cancer cases, with 11 % diagnosed with TNBC 
subtype and 76 % with Her2−/HR+ subtype. About 14 % 
of API cases and 13  % of Hispanic breast cancer cases 
were of TNBC subtypes. About 17  % of all cases were 
diagnosed at stages III and IV, however a higher pro-
portion of TNBC cases (21.3 %) and Her2+/HR− cases 
(29.6 %) were diagnosed at the later stages. Overall 25 % 
of all cases resided in the highest SES census tracts, com-
pared with 14 % in the lowest SES census tracts.
Figure 1 depicts the distribution of breast cancer cases 
within each subtype stratified by age group and SES. The 
majority of cases occurred between ages 50–64  years 
regardless of subtype, although there was a higher pro-
portion of younger cases (<50  years) and lower pro-
portion of older cases (≥75  years) in the Her2+/HR+ 
subtype, and the inverse (lower proportion of younger 
cases and higher proportion of older cases) in the 
Her2−/HR+ subtype. In general, there were no substan-
tial increases in the proportion of breast cancer cases 
with increasing SES, except among younger cases with 
Her2+/HR+ and a smaller increase among younger 
cases with Her2−/HR+ subtype.
In Table 2, age-adjusted incidence rates (IR) and inci-
dence rate ratios (IRR) are presented for each subtype 
by census-tract SES, stratified by race/ethnicity. Overall, 
there was an increased risk of breast cancer with increas-
ing SES in each racial group (p value trend <0.05), with 
estimates ranging from 21  % among NH-Blacks (IRR 
Group 5 vs. 1:1.21, 95 % CI 1.07–1.35), 37 % among NH-
Whites (IRR Group 5 vs. 1: 1.37, 95  % CI 1.22–1.55), 
33 % among NH-API (IRR Group 5 vs. 1: 1.33, 95 % CI 
1.19–1.49), and 37 % among Hispanic cases (IRR Group 
5 vs. 1: 1.37, 95 % CI 1.24–1.52). When stratified by sub-
type, the increased risk associated with SES appeared 
to be driven by associations in the HR+ subtypes; there 
was no significant increased risk in the Her2+/HR− or 
TNBC subtype for any racial group. In contrast, there 
was significantly increased risk associated with increas-
ing SES among NH-Blacks (IRR Group 5 vs. 1:1.36, 95 % 
CI 1.17–1.57), NH-Whites (IRR Group 5 vs. 1: 1.32, 95 % 












 <50 10,093 (21.2) 1444 (14.3) 563 (5.6) 6574 (65.1) 1512 (14.9)
 50–64 18,081 (38.0) 1937 (10.7) 968 (5.4) 12,836 (70.9) 2340 (12.9)
 65–74 10,412 (21.9) 860 (8.3) 354 (3.4) 8127 (78.1) 1071 (10.3)
 ≥75 9000 (18.9) 650 (7.2) 293 (3.3) 7216 (80.2) 841 (9.3)
Race/ethnicity
 NH-White 34,228 (71.9) 3334 (9.7) 1357 (4.0) 25,867 (75.6) 3670 (10.8)
 NH-Black 4503 (9.5) 504 (11.2) 271 (6.0) 2748 (61.0) 980 (21.8)
 NH-API 185 (0.4) 27 (15.0) 10 (5.4) 123 (66.5) 25 (13.5)
 Hispanic 8670 (18.2) 1026 (11.8) 540 (6.2) 6015 (69.4) 1089 (12.6)
AJCC Stage
 I 23,635 (49.7) 1976 (8.4) 727 (3.1) 18,862 (79.8) 2070 (8.8)
 II 14,992 (31.5) 1674 (11.2) 727 (3.1) 10,274 (68.5) 2316 (15.5)
 III 5539 (11.6) 750 (13.5) 441 (7.9) 3466 (62.6) 882 (15.9)
 IV 2332 (4.9) 344 (14.8) 205 (8.8) 1434 (61.5) 349 (14.9)
 Unknown 1067 (2.2) 145 (13.6) 72 (6.7) 716 (67.1) 134 (12.6)
Grade
 Low 10,562 (22.2) 388 (3.7) 27 (0.3) 10,010 (94.8) 137 (1.3)
 Medium 19,841 (41.7) 1907 (9.6) 491 (2.5) 16,470 (83.0) 973 (4.9)
 High 15,055 (31.6) 2336 (15.5) 1521 (10.1) 6784 (45.1) 4414 (29.3)
 Unknown 2128 (4.5) 260 (12.2) 139 (6.5) 1489 (69.9) 240 (11.3)
NCI census tract SES
 Group 1—low 6575 (13.8) 667 (10.1) 350 (5.3) 4533 (68.9) 1025 (15.6)
 Group 2 8254 (17.4) 853 (10.3) 403 (4.8) 5880 (71.2) 1118 (13.5)
 Group 3 9520 (20.0) 1010 (10.6) 438 (4.6) 6968 (73.2) 1104 (11.6)
 Group 4 10,583 (22.2) 1085 (10.3) 460 (4.4) 7837 (74.1) 1201 (11.4)
 Group 5—high 12,006 (25.2) 1214 (10.1) 502 (4.2) 9053 (75.4) 1237 (10.3)
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CI 1.27–1.39), NH-API (IRR Group 5 vs. 1: 1.46, 95 % CI 
1.27–1.68) and Hispanic (IRR Group 5 vs. 1: 1.52, 95  % 
CI 1.35–1.72) cases with Her2−/HR+ subtype. Only 
NH-White (IRR Group 5 vs. 1: 1.46, 95 % CI 1.27–1.68), 
NH-API (IRR Group 3 vs. 1: 1.49, 95 % CI 1.05–2.16) and 
Hispanic (IRR Group 4 vs. 1: 1.41, 95  % CI 1.07–1.86) 
cases with Her2+/HR+ subtypes showed an increased 
risk with higher SES.
Discussion
This study examines the association between census 
tract level SES and the incidence of breast cancer sub-
types among different racial groups in the U.S. Consistent 
with other published studies, we observed higher rates 
of breast cancer incidence among women residing in 
higher SES areas compared with lower SES areas (Vain-
shtein 2008; Yost et al. 2001; Krieger et al. 2006) for HR+ 
subtypes (Her2−/HR+ and Her2+/HR+), but not HR− 
subtypes. This association was observed consistently 
among all racial/ethnic groups. Our findings suggest that 
distinct etiologic pathway(s) exist that contributing to the 
risk of HR− compared with HR+ breast cancer subtypes. 
Differential distribution of such exposure(s) may be the 
source of higher prevalence of HR− subtypes among 
younger, NH-Black, and low SES women (Howlader et al. 
2014; Clarke et al. 2012; Amirikia et al. 2011; Kurian et al. 
2010; Lund et al. 2010).
The association between SES and breast cancer inci-
dence overall has been well characterized. Women of 
higher SES may experience higher breast cancer inci-
dence due to the higher circulatory hormones as a result 
of unique reproductive patterns such as earlier menarche, 
lower parity and later age at first birth (La Vecchia et al. 
1993; Kelsey et al. 1993; Ewertz and Duffy 1988). Higher 

















































































































Fig. 1 Distribution of breast cancer subtypes by age and SES, SEER 2010. Group 1 lowest SES, Group 5 highest SES
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SES women are also more likely to obtain routine mam-
mography screening due to better access to preventive 
healthcare, thereby increasing the detection of breast 
cancer in this group. Although a few recent studies have 
examined the distribution of breast cancer subtypes (Par-
ise et al. 2009; Banegas et al. 2014; Sineshaw et al. 2014), 
only recently have scientists begun to examine tradi-
tional breast cancer risk factors in relation to breast can-
cer hormonal subtypes. For instance, recent studies have 
reported that the association between parity (Aktipis 
et al. 2014; Ritte et al. 2013; Ambrosone et al. 2014; Phi-
pps et  al. 2011) and breastfeeding (Ambrosone et  al. 
2014; Palmer et al. 2014; Redondo et al. 2012), and breast 
cancer likely varies by hormone receptor status. Higher 
parity was associated with increased risk of TNBC, and 
longer duration of breastfeeding was associated with 
reduced risk of TNBC (Ritte et  al. 2013; Redondo et  al. 
2012). Women of low SES may be at higher risk for TNBC 
because they tend to have higher parity (Mosher et  al. 
2012; Stanford and Smith 2013; Burr and Bean 1996) but 
lower breastfeeding rates (Kitsantas et al. 2011; Flacking 
et al. 2010; Flacking et al. 2007). These are patterns that 
have been observed among Non-Hispanic black women 
relative to other racial/ethnic groups (Hamilton et  al. 
2014; Martin et al. 2010; Belanoff et al. 2012; Singh et al. 
2007).
Although there were no associations observed 
between SES and HR− breast cancer subtypes in this 
Table 2 Breast cancer incidence rate (IR) and incidence rate ratios (IRR) by hormone receptor subtype and SES, SEER 2010
Italicized P-value are from Chi-square tests for linear trend for each subtype by SES
¶ P value <0.05, indicates that the rate ratio is significantly different than the rate for Group 1
a Incidence rates are per 100,000 and age-adjusted to the 2000 US standard population
Socio-economic status IRa Breast cancer subtype
IRR
Total Her2+/HR+ Her2+/HR− Her2−/HR+ TNBC
NH-Black
 Group 1—low (Ref ) 134.8 – – – – –
 Group 2 141.0 1.05 (0.96–1.13) 1.12 (0.87–1.44) 0.77 (0.54–1.08) 1.06 (0.95–1.17) 1.08 (0.91–1.28)
 Group 3 153.2 1.14 (1.04–1.24)¶ 1.17 (0.89–1.53) 0.85 (0.58–1.22) 1.22 (1.08–1.36)¶ 0.99 (0.82–1.21)
 Group 4 148.2 1.09 (0.99–1.21) 1.21 (0.89–1.62) 0.98 (0.65–1.45) 1.07 (0.94–1.22) 1.16 (0.94–1.43)
 Group 5—high 162.5 1.21 (1.07–1.35)¶ 1.14 (0.79–1.61) 0.95 (0.56–1.53) 1.36 (1.17–1.57)¶ 0.88 (0.67–1.16)
 P value trend 0.025 0.16 0.82 0.11 0.76
NH-White
 Group 1—low (Ref ) 137.2 – – – – –
 Group 2 144.2 1.05 (1.00–1.10)¶ 1.17 (1.00–1.36) 1.10 (0.87–1.39) 1.05 (0.99–1.11) 0.95 (0.83–1.08)
 Group 3 153.0 1.12 (1.06–1.17)¶ 1.27 (1.09–1.49)¶ 1.11 (0.89–1.39) 1.13 (1.07–1.19)¶ 0.92 (0.81–1.05)
 Group 4 164.2 1.19 (1.15–1.25)¶ 1.32 (1.14–1.52)¶ 1.17 (0.94–1.45) 1.22 (1.16–1.28)¶ 0.98 (0.87–1.12)
 Group 5—high 177.0 1.37 (1.22–1.55)¶ 1.46 (1.27–1.68)¶ 1.23 (0.99–1.52) 1.32 (1.27–1.39)¶ 0.98 (0.87–1.11)
 P value trend 0.007 0.001 0.004 0.009 0.96
NH-API
 Group 1—low (Ref ) 93.1 – – – – –
 Group 2 103.2 1.11 (0.98–1.26) 1.24 (0.85–1.84) 1.03 (0.62–1.72) 1.14 (0.97–1.33) 0.85 (0.56–1.28)
 Group 3 116.3 1.24 (1.11–1.41)¶ 1.49 (1.05–2.16)¶ 1.46 (0.94–2.32) 1.25 (1.08–1.46)¶ 0.84 (0.57–1.26)
 Group 4 122.2 1.31 (1.16–1.48)¶ 1.12 (0.78–1.63) 1.09 (0.98–1.77) 1.41 (1.21–1.63)¶ 1.07 (0.74–1.57)
 Group 5—high 127.6 1.33 (1.19–1.49)¶ 1.32 (0.94–1.91) 1.03 (0.65–1.68) 1.46 (1.27–1.68)¶ 1.12 (0.78–1.62)
 P value trend 0.002 0.44 0.85 0.001 0.31
Hispanic
 Group 1—low (Ref ) 91.2 – – – – –
 Group 2 96.6 1.06 (0.97–1.15) 1.11 (0.86–1.43) 1.18 (0.83–1.67) 1.06 (0.95–1.18) 0.98 (0.79–1.22)
 Group 3 111.5 1.22 (1.12–1.33)¶ 1.27 (0.98–1.65) 0.85 (0.57–1.29) 1.27 (1.14–1.41)¶ 1.16 (0.93–1.44)
 Group 4 115.1 1.26 (1.15–1.39)¶ 1.41 (1.07–1.86)¶ 0.97 (0.63–1.47) 1.38 (1.23–1.54)¶ 0.79 (0.60–1.04)
 Group 5—high 125.2 1.37 (1.24–1.52)¶ 0.97 (0.69–1.35) 1.16 (0.75–1.79) 1.52 (1.35–1.72)¶ 1.09 (0.83–1.43)
 P value trend 0.002 0.74 0.79 0.001 0.97
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study, future studies may contribute to our understand-
ing of this phenomenon by examining individual level 
SES in relation to breast cancer subtypes. While census-
tract SES has been validated as a concrete measure of 
neighborhood SES, it may not fully capture individual 
level variation in SES. Other areas of investigation may 
also focus on population differences in the prevalence 
of both reproductive, lifestyle and environmental risk 
factors that could increase the risk of HR− breast can-
cer. For instance, poor diet and lack of physical activity 
have been shown to be highly associated with the risk of 
metabolic syndrome, a cluster of metabolic abnormali-
ties including obesity, insulin resistance, dyslipidemia 
and hypertension (Martinez et al. 2014; Clark et al. 2013; 
Cubbin et al. 2001). Metabolic syndrome has been asso-
ciated with TNBC in several studies (Vargas-Hernandez 
et al. 2013; Davis and Kaklamani 2012; Maiti et al. 2010), 
and is hypothesized to increase risk of TNBC through 
the association with leptin and adiponectin levels that 
disrupt cell signaling pathways involved in cell cycle 
regulation, angiogenesis and cell proliferation (Davis and 
Kaklamani 2012).
If confirmed by studies adequately powered to account 
for confounders, these are highly modifiable risk factors 
that could be targeted by primary prevention programs. 
In addition, there may be distinct breast tumorigenic 
pathways driven at least partially by an underlying genetic 
or epigenetic pathway, giving rise to HR− tumors.
This is the first population-based study to character-
ize the association between SES and breast cancer sub-
types by racial groups in the U.S. The large sample size 
allowed for stratification by hormone receptor subtype 
in assessing the SES-subtype association, and the use of 
SEER data ensured that all variables were standardized. 
Our results show that HR− breast cancer incidence is 
independent of SES and highlights the need for further 
studies to fully characterize this relationship and identify 
etiologic factors. Studies are needed to examine individ-
ual level SES and associated risk factors (e.g. obesity) for 
HR− tumors, and multilevel studies should examine both 
individual and neighborhood SES. Longitudinal studies 
can be done to account for the induction period between 
exposure and breast cancer development. There are sev-
eral limitations of this study. First, there was no data on 
individual level SES, highlighting the need for further 
studies to determine if the association between census-
tract SES and HR− breast cancer is partially or fully 
mediated by individual SES. Second, we lacked informa-
tion on individual risk factors for breast cancer. This is a 
well-known limitation of cancer registry data studies, and 
we hope that future studies can overcome this limitation 
through the use of primary datasets or by using registry 
data linked with individual level risk factor data.
Conclusion
Contrary to the well-known association of higher breast 
cancer incidence with higher SES, we found that the 
incidence rate of HR− breast cancer subtypes did not 
increase with increasing SES, as measured by the census-
tract level data. There are several other etiologic path-
ways that may lead to HR− breast cancer incidence, and 
future studies are needed to fully characterize those to 
better inform breast cancer prevention strategies.
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